v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2024 $ 0 $ 305,366 $ (47) $ (298,791) $ 6,528
Balance (in Shares) at Dec. 31, 2024 104,142        
Net loss $ 0 0 0 (3,014) (3,014)
Unrealized foreign currency translation adjustment 0 0 (2) 0 (2)
Stock-based compensation $ 0 67 0 0 67
Stock-based compensation (in Shares) 0        
Series J convertible preferred stock deemed dividend $ 0 (1) 0 0 (1)
Balance at Mar. 31, 2025 $ 0 305,432 (49) (301,805) 3,578
Balance (in Shares) at Mar. 31, 2025 104,142        
Balance at Dec. 31, 2025 $ 0 318,928 8 (316,312) 2,624
Balance (in Shares) at Dec. 31, 2025 1,686,217        
Net loss $ 0 0 0 (4,541) (4,541)
Issuance of common stock from exercise of warrants $ 0 4,393 0 0 4,393
Issuance of common stock from exercise of warrants (in Shares) 799,501        
Issuance of common stock from Rendiatech acquisition $ 0 162 0 0 162
Issuance of common stock from Rendiatech acquisition (in Shares) 150,000        
Stock-based compensation $ 0 25 0 0 25
Stock-based compensation (in Shares) 0        
Series J convertible preferred stock deemed dividend $ 0 (2) 0 0 (2)
Balance at Mar. 31, 2026 $ 0 $ 323,506 $ 8 $ (320,853) $ 2,661
Balance (in Shares) at Mar. 31, 2026 2,635,718